These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35693064)

  • 1. BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors.
    De Benedetto I; Barco A; Rossi M; Lapadula G; Lupia T; Bonfanti P; Bonora S; Di Perri G; Calcagno A
    Infez Med; 2022; 30(2):242-246. PubMed ID: 35693064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Eur Urol; 1989; 16(3):161-4. PubMed ID: 2744050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature.
    Manganas K; Angelara M; Bountzona I; Karamanakos G; Toskas A
    Eur J Case Rep Intern Med; 2022; 9(10):003395. PubMed ID: 36415837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review.
    Cabas P; Rizzo M; Giuffrè M; Antonello RM; Trombetta C; Luzzati R; Liguori G; Di Bella S
    Urol Oncol; 2021 Feb; 39(2):85-92. PubMed ID: 33308969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of bacille Calmette-Guérin infections after bladder instillation from 2002 through 2017: a nationwide retrospective cohort study.
    Larsen ES; Nordholm AC; Lillebaek T; Holden IK; Johansen IS
    BJU Int; 2019 Dec; 124(6):910-916. PubMed ID: 31054198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment.
    Becker A; Grunwald IQ; Unger MM; Behnke S; Spiegel J; Yilmaz U; Walter S; Faßbender K
    Front Neurol; 2020; 11():484282. PubMed ID: 33192960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome.
    Waked R; Choucair J; Chehata N; Haddad E; Saliba G
    J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100149. PubMed ID: 32099909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for intravesical instillation postponement during adjuvant treatment of non-muscle-invasive bladder cancer: A prospective study.
    Khan W; Zugail AS; Blanc E; Neuziller Y; Lebret T
    Prog Urol; 2020 Feb; 30(2):75-79. PubMed ID: 31953014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
    Parent ME; Richer M; Liang P
    Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the Recurrence of Superficial Bladder Cancers: Intravesical Instillation of Bacillus Calmette-guerin Versus Bacillus Calmette-guerin Plus Epirubicin.
    Tozawa K; Okamura T; Yamada Y; Hayashi Y; Sasaki S; Kohri K
    Asian Pac J Cancer Prev; 2000; 1(3):217-220. PubMed ID: 12718668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG].
    Mugiya S; Nagata M; Takayama T; Ozono S; Ito T; Maruyama S; Hadano S; Nagae H
    Hinyokika Kiyo; 2004 Jul; 50(7):469-73. PubMed ID: 15334890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
    Vallilas C; Zachou M; Dolkiras P; Sakellariou S; Constantinou CA; Flevari P; Anastasopoulou A; Androutsakos T
    Am J Case Rep; 2021 Oct; 22():e933006. PubMed ID: 34654796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications.
    Zhao LC; Meeks JJ; Helfand BT; Ross FR; Herr HW; Kundu SD
    BJU Int; 2012 Jun; 109(12):1819-21. PubMed ID: 22077819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
    Colomba C; Di Carlo P; Guadagnino G; Siracusa L; Trizzino M; Gioè C; Cascio A
    Infect Agent Cancer; 2016; 11():25. PubMed ID: 27257433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
    Broekx S; Buelens E
    Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.